Page last updated: 2024-10-24

verapamil and Arthritis, Rheumatoid

verapamil has been researched along with Arthritis, Rheumatoid in 2 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Research Excerpts

ExcerptRelevanceReference
" This study was carried out to examine the effect of rheumatoid arthritis (RA) on the pharmacokinetics and pharmacodynamics of verapamil."9.09Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis. ( Jamali, F; Mayo, PR; Russell, AS; Skeith, K, 2000)
"Active rheumatoid arthritis (RA), obesity, and old age are associated with reduced responsiveness to the calcium channel antagonist verapamil despite increased drug concentrations."7.75Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab. ( Ihejirika, B; Jamali, F; Lewanczuk, RZ; Ling, S; Russell, AS, 2009)
" This study was carried out to examine the effect of rheumatoid arthritis (RA) on the pharmacokinetics and pharmacodynamics of verapamil."5.09Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis. ( Jamali, F; Mayo, PR; Russell, AS; Skeith, K, 2000)
"Active rheumatoid arthritis (RA), obesity, and old age are associated with reduced responsiveness to the calcium channel antagonist verapamil despite increased drug concentrations."3.75Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab. ( Ihejirika, B; Jamali, F; Lewanczuk, RZ; Ling, S; Russell, AS, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ling, S1
Lewanczuk, RZ1
Russell, AS2
Ihejirika, B1
Jamali, F2
Mayo, PR1
Skeith, K1

Trials

1 trial available for verapamil and Arthritis, Rheumatoid

ArticleYear
Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis.
    British journal of clinical pharmacology, 2000, Volume: 50, Issue:6

    Topics: Adult; Area Under Curve; Arthritis, Rheumatoid; Calcium Channel Blockers; Female; Humans; Interleuki

2000

Other Studies

1 other study available for verapamil and Arthritis, Rheumatoid

ArticleYear
Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab.
    Journal of clinical pharmacology, 2009, Volume: 49, Issue:3

    Topics: Antibodies, Monoclonal; Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Biological Av

2009